MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Prostate
Myovant Sciences Ltd (NYSE: MYOV)
Organization & Developments: Myovant
Parents
Myovant Sciences Ltd (NYSE: MYOV)
Children
2019: Assessing An Investment In Myovant Sciencesseekingalpha.com
2019: Biotech Analysis Central Preview Series: Myovant Sciencesseekingalpha.com
2019: Myovant Presses Forward After Latest Positive Trial; Multiple Catalysts Loomseekingalpha.com
2020: In groundbreaking move, FDA approves Myovant's relugolix as the first once-a-day pill for advanced prostate cancer
2020: Myovant and Pfizer Ink $4.2 Billion Deal for Orgovyx in Oncology and Women's Health_biospace
2020: Myovant Sciences: More Than Meets The Eye
2020: Myovant_Highly Rated Biotech Rockets To 14-Month High — And Takes Rival With It
2020: Myovant: Relugolix Has Strong Competition
2020: The Sell-Off In Myovant Is Unjustified By Fundamentals
2022: Myovant: Sumitomo Bid Is A Head Scratcher, Where Is The Value_seekingalpha.com
Jumps
*Key People: Myovant
Finance & Acquisitions: Myovant